232 related articles for article (PubMed ID: 22202335)
1. [The clinical outcome of mFOLFOX6 treatment for colorectal cancer patients who underwent resection of liver metastasis -comparison between synchronous and metachronous liver metastasis].
Honjou H; Ishibashi K; Okada N; Tajima Y; Ishiguro T; Kuwabara K; Ohsawa T; Kumamoto K; Tsuji Y; Haga N; Iwama T; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2216-9. PubMed ID: 22202335
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effect of mFOLFOX6 for synchronous unresectable liver metastases from colorectal cancer].
Chikatani K; Ishibashi K; Tajima Y; Hatano S; Amano K; Ishiguro T; Kuwabara K; Sobajima J; Ohsawa T; Okada N; Kumamoto K; Haga N; Iwama T; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2211-3. PubMed ID: 22202333
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
[TBL] [Abstract][Full Text] [Related]
4. [Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases].
Zhang ZG; Song C; Wang H
Ai Zheng; 2006 May; 25(5):596-8. PubMed ID: 16687081
[TBL] [Abstract][Full Text] [Related]
5. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
[TBL] [Abstract][Full Text] [Related]
6. [FOLFOX as adjuvant chemotherapy after curative resection of distant metastatic lesions in patients with colorectal cancer].
Nozawa H; Kitayama J; Sunami E; Saito S; Kanazawa T; Kazama S; Yazawa K; Kawai K; Mori K; Nagawa H
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1627-32. PubMed ID: 21996957
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy comprising modified FOLFOX6 after curative resection of synchronous or metachronous metastasis from colorectal cancer].
Hatano S; Ishibashi K; Amano K; Ishiguro T; Kuwabara K; Sobajima J; Ohsawa T; Okada N; Kumagai Y; Kumamoto K; Baba H; Tsuji Y; Haga N; Ishida H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2192-4. PubMed ID: 23268020
[TBL] [Abstract][Full Text] [Related]
8. FOLFOX as adjuvant chemotherapy after curative resection of distant metastases in patients with colorectal cancer.
Nozawa H; Kitayama J; Sunami E; Saito S; Kanazawa T; Kazama S; Yazawa K; Kawai K; Mori K; Nagawa H
Oncology; 2011; 80(1-2):84-91. PubMed ID: 21677451
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic metastatectomy of colorectal cancer following mFOLFOX6 treatment--analysis of 7 cases].
Okada N; Ishibashi K; Yokoyama M; Kuwabara K; Hatano S; Ishii M; Kubota S; Chika N; Tamaru J; Miyazaki T; Ishida H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2028-31. PubMed ID: 20037313
[TBL] [Abstract][Full Text] [Related]
10. [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6].
Fukuda H; Tazawa K; Sawada S; Nagata T; Uotani H; Hirokawa S; Yamagishi F; Tsukada K
Gan To Kagaku Ryoho; 2008 Mar; 35(3):507-9. PubMed ID: 18347406
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
12. [Recurrance of disappearing colorectal liver metastases after mFOLFOX6 regimen].
Ono T; Okada N; Kumamoto K; Ishibashi K; Haga N; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2214-5. PubMed ID: 22202334
[TBL] [Abstract][Full Text] [Related]
13. [A case of liver metastasis of rectal cancer demonstrating complete response for more than two years to mFOLFOX6].
Miyo M; Kato T; Miyake Y; Kato A; Sakamoto T; Doi T; Hoshi M; Makari Y; Oshima S; Iijima S; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2160-2. PubMed ID: 20037356
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
15. A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
Uetake H; Yasuno M; Ishiguro M; Kameoka S; Shimada Y; Takahashi K; Watanabe T; Muro K; Baba H; Yamamoto J; Mizunuma N; Tamagawa H; Mochizuki I; Kinugasa Y; Kikuchi T; Sugihara K
Ann Surg Oncol; 2015 Mar; 22(3):908-15. PubMed ID: 25465375
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy with FOLFOX4 regimen after curative resection of liver metastases from colorectal cancer].
Ohnishi T; Kanoh T; Tono T; Danno K; Watanabe A; Nakamura H; Tsukao Y; Inatome J; Kim T; Kagara N; Taniguchi H; Kimura Y; Nakano Y; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2554-6. PubMed ID: 21224637
[TBL] [Abstract][Full Text] [Related]
17. [Prediction of the efficacy of modified FOLFOX6 therapy according to the mRNA levels of thymidylate synthase (TS), excision repair cross-complementing-1 and -2( ERCC-1 and ERCC-2) and methylenetetrahydrofolate dehydrogenase( MTHFD) in the primary lesion of colorectal cancer].
Ishibashi K; Okada N; Tajima Y; Ishiguro T; Kuwabara K; Ohsawa T; Kumamoto K; Tsuji Y; Haga N; Iwama T; Ishida H; Onouchi T; Yakabi K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2220-3. PubMed ID: 22202336
[TBL] [Abstract][Full Text] [Related]
18. 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.
van der Pool AE; Lalmahomed ZS; Ozbay Y; de Wilt JH; Eggermont AM; Jzermans JN; Verhoef C
Colorectal Dis; 2010 Oct; 12(10 Online):e229-35. PubMed ID: 19912286
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
Umehara M; Umehara Y; Takahashi K; Murata A; Nishikawa S; Tokura T; Matsuzaka M; Tanaka R; Morita T
Anticancer Res; 2016 Apr; 36(4):1949-54. PubMed ID: 27069185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
